惰性淋巴增生性疾病的临床试验
总计144280个结果
-
National Cancer Institute (NCI)完全的
-
Guangxi Medical University完全的
-
Ruijin HospitalShanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd未知
-
Massachusetts General HospitalDana-Farber Cancer Institute; Adienne SA撤销
-
Sinobioway Cell Therapy Co., Ltd.Jiangsu Cancer Institute & Hospital未知
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College...终止
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
Lymphoma Trials Office未知
-
Armando Santoro, MD未知
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
HemaQuest Pharmaceuticals Inc.Boston University终止
-
National Cancer Institute (NCI)招聘中
-
University of East AngliaClinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)未知
-
Weill Medical College of Cornell University完全的
-
Celldex TherapeuticsMerck Sharp & Dohme LLC完全的黑色素瘤 | 滤泡性淋巴瘤 | 肾细胞癌 | 乳腺癌 | 头颈癌 | 胃癌 | 大肠癌 | 食道癌 | 胰腺癌 | 卵巢癌 | 输卵管癌 | 套细胞淋巴瘤 | 边缘区淋巴瘤 | 淋巴浆细胞性淋巴瘤 | 非霍奇金淋巴瘤 | 胆管癌 | 非小细胞肺癌 | 原发性腹膜癌 | 肝癌 | 弥漫性大 B 细胞淋巴瘤 (DLBCL) | 膀胱尿路上皮癌 | 其他实体瘤 | 小淋巴细胞白血病 | 华氏病 | 惰性 B 细胞淋巴瘤 | 粘膜相关淋巴组织美国
-
National Cancer Institute (NCI)完全的
-
Celgene主动,不招人
-
M.D. Anderson Cancer CenterBiogen; CTI BioPharma完全的